Home > Insider Trading > Filing (0001179110-13-015751)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
203077	St Jude Medical Inc	STJ	Electromedical & Electrotherapeutic Apparatus (3845)	411276891

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532763	Jason Zellers	One St. Jude Medical Drive St. Paul MN 55117	Vp, General Counsel & Corp Sec	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-10-23	574	$56.73	913	No	4	S	Indirect	By Spouse
Common Stock	Acquisiton	2013-10-24	260	$30.58	1,173	No	4	M	Indirect	By Spouse
Common Stock	Disposition	2013-10-24	260	$56.24	913	No	4	S	Indirect	By Spouse
Common Stock	Acquisiton	2013-10-25	750	$38.59	1,663	No	4	M	Indirect	By Spouse
Common Stock	Disposition	2013-10-25	750	$57.10	913	No	4	S	Indirect	By Spouse
Common Stock	Acquisiton	2013-10-25	13,333	$34.96	15,019	No	4	M	Direct
Common Stock	Disposition	2013-10-25	13,333	$57.19	1,686	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Spouse
No	4	M	Indirect	By Spouse
No	4	S	Indirect	By Spouse
No	4	M	Indirect	By Spouse
No	4	S	Indirect	By Spouse
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-10-24	260	$0.00	260	$30.58
Common Stock	Common Stock (Right to Buy)	Disposition	2013-10-25	750	$0.00	750	$38.59
Common Stock	Stock Option (Right to Buy)	Disposition	2013-10-25	13,333	$0.00	13,333	$34.96

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-12-15	2016-12-15	No	4	M	Indirect
250	2010-12-14	2017-12-14	No	4	M	Indirect
39,999	2012-12-17	2019-12-12	No	4	M	Direct

Footnotes

The option shares vest 25% on each of the first four anniversary dates of the date of the grant beginning on the date shown.
The price in Column 4 is a weighted average. The prices actually received ranged from $57.15 to $57.26. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Fully vested at the time of filing.